Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The FDA has released a draft guidance document intended to help medical device labelers and FDA staff understand the FDA's requirements for direct marketing of devices for unique device identificaiton purposes.
Supplying patients with tools such as tablets and patient portal apps does not have a great impact on their understanding of their care and treatment, according to a study published in theJournal of the American Medical Informatics Association.
Health information organizations are using Direct messaging in support of care coordination use cases but there is great variability in the method of access.
More than half of U.S. residents want to access health information via their physicians' websites, but few currently do so, according to findings published in the Journal of General Internal Medicine.
A coalition of 31 organizations has voiced its support for the interoperability language included in the 21st Century Cures Act (HR 6) in a letter to the House Energy and Commerce Committee.
This week, the U.S. Supreme Court ruled on that the subsidies offered as part of the Affordable Care Act (ACA) will be available nationwide, regardless of whether they are used to buy health insurance on an exchange established by the federal government or an individual state.
New York, NY (June 25, 2015) – Cureatr, Inc. today announced it has closed on $13 million in Series B financing in a round led by Deerfield Investments, a healthcare technology private-equity firm in New York.
WASHINGTON - Tuesday, June 23, 2015 - The American Telemedicine Association (ATA) has awarded accreditation for online patient consultations to CareSimple and MDLIVE. Four organizations have been accredited since the program’s launch this year and approximately 300 organizations have registered for the program.
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks.
Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.
